Dr. Reddy’s launches Sapropterin Dihydrochloride Tablets generic version in US

pharmanewsdaily- October 4, 2020

Indian pharma company Dr. Reddy’s Laboratories has launched a generic version of phenylalanine hydroxylase activator Sapropterin Dihydrochloride Tablets, for oral use, in the US market. ... Read More